GlassScriptPhysician profile
Kerry N Gott
NPI 1013955186
$1,169.90
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $103 · 2021: $282 · 2022: $278 · 2023: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $454.27 | 2019-2023 | Grafix Pl |
| Bioventus LLC | $140.96 | 2019 | |
| Organogenesis INC. | $124.78 | 2019 | |
| Convatec INC. | $95.49 | 2020-2022 | |
| Medline Industries LP | $57.56 | 2019-2023 | |
| Tactile Systems Technology INC | $49.58 | 2021-2022 | |
| Kci USA, INC. | $37.36 | 2020-2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Biotissue Holdings INC. | $33.57 | 2022-2023 | |
| Venclose INC. | $29.75 | 2020 | |
| Medtronic Vascular, INC. | $27.45 | 2019 | |
| Ovik Health, LLC | $26.02 | 2023 | |
| Nuo Therapeutics | $25.47 | 2022 | |
| Boston Scientific Corporation | $22.85 | 2022 | |
| Bard Peripheral Vascular, INC. | $18.48 | 2023 | Venclose Maven Catheter |
| Melinta Therapeutics, LLC | $14.51 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Gott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.